| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/18/2013 | CN103301419A Health-care oral liquid |
| 09/18/2013 | CN103301403A Chinese medicine composition for treating pain in terminal cancers |
| 09/18/2013 | CN103301397A Traditional Chinese medicine amber and turmeric root tuber powder for treating epilepsy |
| 09/18/2013 | CN103301396A Traditional Chinese medicine alum and manyleaf paris rhizome powder for treating epilepsy |
| 09/18/2013 | CN103301369A Pharmaceutical composition for preventing encephalatrophy |
| 09/18/2013 | CN103301368A Medicament for treating hyperactivity |
| 09/18/2013 | CN103301344A Chinese medicine oral liquid applied to maintain beauty and keep young |
| 09/18/2013 | CN103301328A Trigeminal neuralgia treatment medicine |
| 09/18/2013 | CN103301327A Medicine for treating headache and preparation method thereof |
| 09/18/2013 | CN103301325A Traditional Chinese medicine for treating neurasthenia |
| 09/18/2013 | CN103301324A Traditional Chinese medicine for treating nerve headache |
| 09/18/2013 | CN103301307A Chinese herbal medicine for treating diabetes mellitus |
| 09/18/2013 | CN103301300A Traditional Chinese medicine preparation for treating vegetative nerve disturbance |
| 09/18/2013 | CN103301294A Pharmaceutical composition for treating idiopathic trigeminal neuralgia |
| 09/18/2013 | CN103301290A Compound longan polysaccharide immune foundation-strengthening prescription and preparation method thereof |
| 09/18/2013 | CN103301273A Smoking cessation traditional Chinese medicine and preparation method thereof |
| 09/18/2013 | CN103301269A Traditional Chinese medicine pharbitis seed powder for treating epilepsy |
| 09/18/2013 | CN103301245A Medicament for reinforcing qi, nourishing blood and nourishing liver and kidney |
| 09/18/2013 | CN103301236A Preparation method of six-ingredient capsule |
| 09/18/2013 | CN103301222A Chinese patent medicine for treating hemiplegia sequela |
| 09/18/2013 | CN103301217A Composition and applications thereof, pharmaceutical preparation and health-care product |
| 09/18/2013 | CN103301214A Improved preparation process of aconite injection |
| 09/18/2013 | CN103301194A Preparation technology of cold-pressed perilla seed oil capsule and its product |
| 09/18/2013 | CN103301190A Extracts of vietnamese sophora root and application thereof |
| 09/18/2013 | CN103301180A Selenium-enriched ganoderan and preparation method thereof |
| 09/18/2013 | CN103301178A Fatigue syndrome prevention and treatment oral drug |
| 09/18/2013 | CN103301159A Traditional Chinese medicine antelope and scorpio powder for treating facioplegia |
| 09/18/2013 | CN103301158A Traditional Chinese medicine dry earthworm and zaocys dhumnade powder for treating epilepsy |
| 09/18/2013 | CN103301157A Traditional Chinese medicine earthworm and stiff silkworm powder for treating epilepsy |
| 09/18/2013 | CN103301145A Medical application of astragaloside |
| 09/18/2013 | CN103301137A Application of aspirin in treatment of cognitive and behavioral disorders after epilepsy |
| 09/18/2013 | CN103301124A Medicine composition for treating epilepsy |
| 09/18/2013 | CN103301119A Edaravone composition for injection |
| 09/18/2013 | CN103301115A Medicine composition for treating epilepsy |
| 09/18/2013 | CN103301114A Oxiracetam medicinal composition, and preparation method and application thereof |
| 09/18/2013 | CN103301104A Use of danshinolic acid A composition in preparing ischemic penumbra treatment medicaments |
| 09/18/2013 | CN103301101A Novel 2-(2-fluorine-4biphenyl)-propionic acid pharmaceutical composition |
| 09/18/2013 | CN103301100A Compound medicine composition |
| 09/18/2013 | CN103301094A Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation |
| 09/18/2013 | CN103301091A Gastrodin double-pulse drug-release preparation |
| 09/18/2013 | CN103301082A Oral tablet with tofisopam as active ingredient, and application of oral tablet |
| 09/18/2013 | CN103300653A Medicine pillow used for health care and health preservation and traditional Chinese medicine formula thereof |
| 09/18/2013 | CN103300649A Fragrant pillow benefiting health |
| 09/18/2013 | CN103055273B Three-original ecology tracing stasis-clearing detoxification health traditional Chinese medicine and preparation method thereof |
| 09/18/2013 | CN102949469B Applications of thalictrum aquilegifolium extract in preparing medicine treating alzheimer's disease |
| 09/18/2013 | CN102836354B Medicament for treating depression |
| 09/18/2013 | CN102787054B Wind-dispelling healthcare liquor |
| 09/18/2013 | CN102771861B Functional drink recipe for preventing three-high, fat and inner fire and manufacturing method of functional drink recipe for preventing three-high, fat and inner fire |
| 09/18/2013 | CN102552128B Quetiapine fumarate injection and preparation method thereof |
| 09/18/2013 | CN102488841B Capsule or tablet for assisting memory improvement and preparation method thereof |
| 09/18/2013 | CN102379908B Wall breaking method for fresh and live ganoderma lucidum spores |
| 09/18/2013 | CN102357236B Traditional Chinese medicine for treating facial neuritis |
| 09/18/2013 | CN102140470B Human miR-1236 antisense ribonucleic acid and application thereof |
| 09/18/2013 | CN101851165B Glutamate of O-demethyl-venlafaxine and preparation method thereof |
| 09/18/2013 | CN101822673B Iloperidone-containing solid medicinal composition |
| 09/18/2013 | CN101560199B Preparation method of Escitalopram |
| 09/18/2013 | CN101531634B High-purity blonanserin and preparation method thereof |
| 09/18/2013 | CN101463061B Ginseng saponin Rg1 and Rb1 in pseudo-ginseng and preparation of total saponin thereof |
| 09/18/2013 | CN101413143B Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 09/18/2013 | CN101384581B Benzoyl-piperidine derivatives as 5HT2/D3 modulators |
| 09/18/2013 | CN101293831B Uses of 3-hydroxy fatty acid and its derivative in preparing calcium ion duct modifying agent |
| 09/17/2013 | US8536348 Lactone formulations and method of use |
| 09/17/2013 | US8536229 Acetylene derivatives having MGluR 5 antagonistic activity |
| 09/17/2013 | US8536164 Fused pyridine compounds as casein kinase inhibitors |
| 09/17/2013 | US8535721 Pharmaceutical microspheres containing valproic acid for oral administration |
| 09/17/2013 | US8535715 Bilayer tablet formulations |
| 09/17/2013 | US8535673 A humanized antibody that specifically binds an epitope contained within positions 13-28 of A beta; used for treating Alzheimer's disease in both asymptomatic patients and those currently showing symptoms of disease. |
| 09/17/2013 | CA2694209C Azepine derivatives as gamma-secretase inhibitors |
| 09/17/2013 | CA2604562C Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2) |
| 09/17/2013 | CA2562685C Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 09/17/2013 | CA2531980C Imide derivatives as therapeutic agents for senile dementia |
| 09/17/2013 | CA2451738C Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine |
| 09/17/2013 | CA2348382C Chimeric parvovirus vectors and methods of making and administering the same |
| 09/12/2013 | WO2013134766A2 Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders |
| 09/12/2013 | WO2013134403A1 Method of treating neurodegenerative diseases with microrna regulators |
| 09/12/2013 | WO2013134371A1 Methods and compounds to be used in the treatment of neurodegenerative diseases |
| 09/12/2013 | WO2013134228A1 PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE |
| 09/12/2013 | WO2013134219A1 Imidazo [1, 2 - b] pyridazine - based compounds, compositions comprising them, and uses thereof |
| 09/12/2013 | WO2013134085A1 Inhibitors of beta-secretase |
| 09/12/2013 | WO2013134036A1 Aryl ether-base kinase inhibitors |
| 09/12/2013 | WO2013133650A1 Pharmaceutical composition for preventing, alleviating or treating diseases associated with cranial nerves or spinal nerves, containing stem cell-conditioned culture medium powder |
| 09/12/2013 | WO2013133647A1 Stable liquid pharmaceutical composition containing piroxicam or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt and the manufacturing method thereof |
| 09/12/2013 | WO2013133448A1 Sustained release oral solid preparation |
| 09/12/2013 | WO2013133325A1 Tricyclic compound |
| 09/12/2013 | WO2013132490A1 Compositions and methods of treatment of status epilepticus |
| 09/12/2013 | WO2013132489A1 Nucleoside 5'-phosphorothioate analogues and uses thereof |
| 09/12/2013 | WO2013132380A1 Thiazole derivatives as alpha 7 nachr modulators |
| 09/12/2013 | WO2013132270A1 Phosphoinositide 3-kinase inhibitors |
| 09/12/2013 | WO2013043232A8 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer |
| 09/12/2013 | US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain |
| 09/12/2013 | US20130237721 Therapeutic compounds and methods of use |
| 09/12/2013 | US20130237608 Prolonged Release Pharmaceutical Composition Containing 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)Phenol |
| 09/12/2013 | US20130237526 Pharmaceutical composition |
| 09/12/2013 | US20130236452 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 09/12/2013 | US20130236446 Treatment of migraine headache with diffusion of toxin in non-muscle related areas of the mouth |
| 09/12/2013 | US20130236444 Treatment of migraine headache with diffusion of toxin in non-muscle related foraminal sites |
| 09/11/2013 | EP2636672A1 Imidazole derivatives and preparation method and use thereof |
| 09/11/2013 | EP2636666A1 Trans-2-decenoic acid derivative and medicament containing same |
| 09/11/2013 | EP2635686A2 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord |
| 09/11/2013 | EP2635581A1 7-([1,2,3]triazol-4-yl)-pyrrolo[2,3-b]pyrazine derivatives |